Similar articles

• Vaccines based on recombinant antigen strategies.

  Minor P. Minor P. Dev Biol (Basel). 2001;105:189-94. Dev Biol (Basel). 2001. PMID: 11763327 Review. No abstract available.
• Rapid and accurate identification of poliovirus strains used for vaccine production.

  Nijst OE, Mouthaan JJ, Mekkes DR, Jusic E, van der Avoort HG, Metz B. Nijst OE, et al. J Virol Methods. 2013 Apr;189(1):189-95. doi: 10.1016/j.jviromet.2013.01.026. Epub 2013 Feb 19. J Virol Methods. 2013. PMID: 23434540
• Anomalous observations on IPV and OPV vaccination.

  John TJ. John TJ. Dev Biol (Basel). 2001;105:197-208. Dev Biol (Basel). 2001. PMID: 11763328
• Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.

  Dragunsky EM, Ivanov AP, Wells VR, Ivshina AV, Rezapkin GV, Abe S, Potapova SG, Enterline JC, Hashizume S, Chumakov KM. Dragunsky EM, et al. J Infect Dis. 2004 Oct 15;190(8):1404-12. doi: 10.1086/424524. Epub 2004 Sep 20. J Infect Dis. 2004. PMID: 15378432
• Poliovirus vaccines.

  Racaniello VR. Racaniello VR. Biotechnology. 1992;20:205-22. doi: 10.1016/b978-0-7506-9265-6.50015-4. Biotechnology. 1992. PMID: 1318134 Review. No abstract available.